We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

230 hedge funds and large institutions have $3.19B invested in Axonics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 102 increasing their positions, 68 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more call options, than puts

Call options by funds: $9.1M | Put options by funds: $4.01M

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

50% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 68

42% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 24

10% more capital invested

Capital invested by funds: $2.89B → $3.19B (+$299M)

4% more funds holding

Funds holding: 221230 (+9)

Holders
230
Holders Change
+9
Holders Change %
+4.07%
% of All Funds
3.35%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
34
Increased
102
Reduced
68
Closed
24
Calls
$9.1M
Puts
$4.01M
Net Calls
+$5.09M
Net Calls Change
+$3.63M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$338M +$48.5M +867,563 +19%
Vanguard Group
2
Vanguard Group
Pennsylvania
$327M -$83K -1,484 -0%
BlackRock
3
BlackRock
New York
$261M +$15.4M +275,707 +7%
CIP
4
Champlain Investment Partners
Vermont
$119M -$5.39M -96,268 -5%
BG
5
Bellevue Group
Switzerland
$114M -$23.5M -419,686 -19%
Invesco
6
Invesco
Georgia
$114M +$10.6M +189,862 +12%
BAMCO Inc
7
BAMCO Inc
New York
$112M -$98.9K -1,768 -0.1%
Axa
8
Axa
France
$97.7M -$8.87M -158,645 -9%
Loomis, Sayles & Company
9
Loomis, Sayles & Company
Massachusetts
$81M +$2.73M +48,726 +4%
HRCM
10
Hood River Capital Management
Florida
$80.8M -$3.07M -54,815 -4%
Mackenzie Financial
11
Mackenzie Financial
Ontario, Canada
$77.8M +$608K +10,872 +0.9%
Artisan Partners
12
Artisan Partners
Wisconsin
$76M +$32.7M +583,958 +92%
State Street
13
State Street
Massachusetts
$74.9M +$2.65M +47,286 +4%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$68.6M +$3.37M +60,308 +6%
CS
15
Credit Suisse
Switzerland
$61.2M -$5.72M -102,312 -9%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$57.4M +$3.16M +56,418 +7%
Amundi
17
Amundi
France
$47.3M -$816K -14,592 -2%
WA
18
Wasatch Advisors
Utah
$43.8M +$282K +5,046 +0.7%
Northern Trust
19
Northern Trust
Illinois
$39.9M +$1.72M +30,680 +5%
Goldman Sachs
20
Goldman Sachs
New York
$38.7M +$2.25M +40,306 +7%
Norges Bank
21
Norges Bank
Norway
$37.6M -$38.7M -691,166 -53%
N
22
Nuveen
North Carolina
$37M -$34.8K -622 -0.1%
Macquarie Group
23
Macquarie Group
Australia
$36.3M +$3.64M +65,085 +13%
Neuberger Berman Group
24
Neuberger Berman Group
New York
$36.1M +$2.57M +45,955 +9%
Morgan Stanley
25
Morgan Stanley
New York
$35.7M +$20.2M +361,295 +170%

AXNX Hedge Fund Activity: Q4 2023 in Review

230 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q4 2023, worth a combined $3.19B — up 10% from $2.89B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new AXNX positions and 24 closed out — a net gain of 10 holders — while 102 added to existing stakes and 68 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $48.5M. The largest seller was Norges Bank, cutting an estimated $38.7M.

  • 230 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q4 2023, up from 221 in Q3 2023.
  • Funds reported $3.19B of Axonics, Inc. Common Stock stock for Q4 2023, up 10% quarter-over-quarter.
  • 34 funds opened new Axonics, Inc. Common Stock positions in Q4 2023 and 24 closed out, a net change of +10 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q4 2023 was Fidelity Investments, an estimated $48.5M added.
  • The largest Axonics, Inc. Common Stock seller in Q4 2023 was Norges Bank, an estimated $38.7M sold.

Based on aggregated 13F filings for Q4 2023.